Vas Narasimhan on the future of pharma, plus Moderna’s vaccine promise & a biotech presidential bid

Turns out Vas is a big fan of our podcast.

February 17, 2023 Check out STAT+

Sponsored By

Is the pharmaceutical lobby on the ropes? What does it mean when a vaccine is "free"? And does biotech prepare you for the presidency? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry's struggles in Washington and whether the deflated biotech sector is still overvalued. We also dive into the latest news in the life sciences, including Moderna's promise of no-cost Covid-19 vaccines and biotech entrepreneur Vivek Ramaswamy's potential run for president. Listen Now Subscribe to the podcast to never miss an episode iTunes SoundCloud Stitcher TuneIn Google Play Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser